Printed 19/06/2013
Url http://www.dkma.dk/en/topics/side-effects-and-trials/clinical-trials/news/use-of-waivers-in-connection-with-the-in--cal-trials
MEDICINES HEALTH Shortcuts to sst.dk
Print Print Share Share #MISSING TRANSLATION: PageBar.SendToFriendTooltip# Email Large font-sizeNormal font-sizeSmall font-size
Side effects and trials

Use of waivers in connection with the inclusion of trial subjects/patients in clinical trials

The EMEA GCP Inspectors Working Group has prepared a document with a common European position on the use of waivers in connection with the inclusion of trial subjects/patients in clinical trials.

See the document in the factbox to the right.

The Danish Medicines Agency, 11 January 2008.

Related content
Created 11 January 2008
Service
Themes Publications Questions and answers Sitemap

Newsletter

RSS feed RSS

QUESTIONS AND ANSWERS

About DKMAnet

About clinical trials

About counterfeit medicines

All Questions and answers

DKMAnet

Access-controlled extranet, which offers companies easy and secure access to sending and receiving information.

Log onto DKMAnet using Digital Signature

About DKMAnet

Danish Health and Medicines Authority
Axel Heides Gade 1
2300 Copenhagen S, Denmark


Contact us
CVR and EAN numbers